Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a ...

Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...

Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...

Image: CC] On Tuesday, Boston-based biotech startup Life Biosciences announced the dosing of its first patient with a cellular reprogramming injection, designed to reverse age-re ...

Armed with a fully subscribed $80 million series D round, Life Biosciences Inc. is making progress with its lead candidate, ER-100, which is in phase I trials testing its theory on reversing the ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...